Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Oct 7;311(7010):928–931. doi: 10.1136/bmj.311.7010.928

Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study.

I L Chrystie 1, C D Wolfe 1, J Kennedy 1, L Zander 1, A Tilzey 1, J E Banatvala 1
PMCID: PMC2550924  PMID: 7580555

Abstract

Despite the increasing advantages of identifying HIV infection in pregnant women, only some 12% of HIV positive women attending antenatal clinics in London have been identified by named testing. As virtually all antenatal care will be community based within the next two to three years, we assessed the problems of introducing named HIV testing during pregnancy into the primary care setting. Planning the service took a considerable time and required the production of educational material for both staff and pregnant women and some reorganisation of procedures. Over a one year period an uptake of 44% was noted. Several problems were encountered including an average of 21 minutes needed to give information on AIDS and HIV, an adverse effect on the midwife-mother relationship, and anxiety (affecting both women and midwives). Possible solutions to this difficult problem are discussed.

Full text

PDF
929

Images in this article

929p929-a
on p.929

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E., Parker S., Cubitt D., Davison C., Holland F., Berry T., Hjelm M., Wilcox A. H., Peckham C. S. Two methods for assessing the risk-factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988-1991. AIDS. 1992 Sep;6(9):1031–1036. doi: 10.1097/00002030-199209000-00018. [DOI] [PubMed] [Google Scholar]
  2. Barbacci M., Repke J. T., Chaisson R. E. Routine prenatal screening for HIV infection. Lancet. 1991 Mar 23;337(8743):709–711. doi: 10.1016/0140-6736(91)90286-x. [DOI] [PubMed] [Google Scholar]
  3. Boyer P. J., Dillon M., Navaie M., Deveikis A., Keller M., O'Rourke S., Bryson Y. J. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994 Jun 22;271(24):1925–1930. [PubMed] [Google Scholar]
  4. Chrystie I. L., Palmer S. J., Kenney A., Banatvala J. E. HIV seroprevalence among women attending antenatal clinics in London. Lancet. 1992 Feb 8;339(8789):364–364. doi: 10.1016/0140-6736(92)91682-x. [DOI] [PubMed] [Google Scholar]
  5. Chrystie I. L., Zander L., Tilzey A., Wolfe C. D., Kenney A., Banatvala J. E. Is HIV testing in antenatal clinics worthwhile? Can we afford it? AIDS Care. 1995;7(2):135–145. doi: 10.1080/09540129550126650. [DOI] [PubMed] [Google Scholar]
  6. Chrystie I., Sumner D., Palmer S., Kenney A., Banatvala J. Screening of pregnant women for evidence of current hepatitis B infection: selective or universal? Health Trends. 1992;24(1):13–15. [PubMed] [Google Scholar]
  7. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  8. Cozen W., Mascola L., Enguidanos R., Bauch S., Giles M., Paxton P., Henneman C., Finn M. Screening for HIV and hepatitis B virus in Los Angeles County prenatal clinics: a demonstration project. J Acquir Immune Defic Syndr. 1993 Jan;6(1):95–98. [PubMed] [Google Scholar]
  9. Delamothe T. HIV infection concentrated in London. BMJ. 1995 Jan 28;310(6974):213–213. doi: 10.1136/bmj.310.6974.213. [DOI] [PubMed] [Google Scholar]
  10. Desmond N., Morgan H., Kell P. Knowledge about tests for HIV antibodies among pregnant women. BMJ. 1994 Oct 1;309(6958):877–877. doi: 10.1136/bmj.309.6958.877a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dunn D. T., Newell M. L., Ades A. E., Peckham C. S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992 Sep 5;340(8819):585–588. doi: 10.1016/0140-6736(92)92115-v. [DOI] [PubMed] [Google Scholar]
  12. HIV screening in pregnancy. Lancet. 1991 May 18;337(8751):1218–1219. [PubMed] [Google Scholar]
  13. Holland F. J., Ades A. E., Davison C. F., Parker S., Berry T., Hjelm M., Wilcox A. H., Cubitt D., Hudson C. N., Peckham C. S. Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes. J Med Screen. 1994 Jul;1(3):176–179. doi: 10.1177/096914139400100308. [DOI] [PubMed] [Google Scholar]
  14. Howard L. C., Hawkins D. A., Marwood R., Shanson D. C., Gazzard B. G. Transmission of human immunodeficiency virus by heterosexual contact with reference to antenatal screening. Br J Obstet Gynaecol. 1989 Feb;96(2):135–139. doi: 10.1111/j.1471-0528.1989.tb01651.x. [DOI] [PubMed] [Google Scholar]
  15. Meadows J., Catalan J. HIV seroprevalence and antenatal clinics. Lancet. 1992 Mar 7;339(8793):622–623. [PubMed] [Google Scholar]
  16. Meadows J., Catalan J. Why do antenatal attenders decide to have the HIV antibody test? Int J STD AIDS. 1994 Nov-Dec;5(6):400–404. doi: 10.1177/095646249400500604. [DOI] [PubMed] [Google Scholar]
  17. Nicoll A., McGarrigle C., Heptonstall J., Parry J., Mahoney A., Nicholas S., Hutchinson E., Gill O. N. Prevalence of HIV infection in pregnant women in London and elsewhere in England. BMJ. 1994 Aug 6;309(6951):376–377. doi: 10.1136/bmj.309.6951.376a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES